ScRNAseq of EGFR-mut PC9 cells control or treated for 24h or 72h with osimertinib
Ontology highlight
ABSTRACT: The experiment investigates transcriptional reponse of EGFR-mut PC9 lung cancer cells following treatment for 24h or 72h with EGFR-inhibitor osimertinib compared to control cells on a single cell level.
INSTRUMENT(S): Illumina HiSeq 4000
ORGANISM(S): Homo sapiens
SUBMITTER: Johannes Braegelmann
PROVIDER: E-MTAB-9468 | biostudies-arrayexpress |
REPOSITORIES: biostudies-arrayexpress
ACCESS DATA